CRISTINA MEEHAN: Open Payments
NPI 1598240830 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100,759 in 295 payments from 12 companies in 2025. Trend: 2023 $39,160 · 2024 $79,901 · 2025 $100,759
Honoraria: $44,368Speaker / faculty: $39,900Travel & lodging: $10,955Food & beverage: $5,536
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 85 | $51,365 |
| ABBVIE INC. | 124 | $47,764 |
| Corium, LLC | 34 | $586 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $376 |
| Neurocrine BioSciences, Inc. | 5 | $208 |
| Alkermes, Inc. | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 4 | $84 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
Products named: Auvelity, VRAYLAR, Azstarys, CAPLYTA, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, Jornay PM.
Industry payments across CT — which companies pay providers there.
